COLPOSCOPY QUALITY CONTROL GROUP FOR THE ASCUS/LSIL CLINICALMANAGEMENT TRIAL NIH GUIDE, Volume 23, Number 40, November 18, 1994 RFP AVAILABLE: NCI-CN-55042-07 P.T. 34 Keywords: Cancer/Carcinogenesis Instrumentation, Medical Clinical Trial National Cancer Institute The National Cancer Institute, Division of Cancer Prevention and Control, is soliciting proposals for a Colposcopy Quality Control (QC) Group that will be responsible for overseeing all aspects of randomized clinical trial involving colposcopy and the taking of cervical biopsies among 3,600 women with the cervical cytologic diagnoses of "atypical squamous cells of undetermined significance" (ASCUS) and 3,600 women with "low-grade squamous intra-epithelial lesions" (LSIL). The Colposcopy QC Group shall be responsible for overseeing the quality of all aspects of the Trial involving colposcopies and the taking of cervical biopsies. The general requirements include: (1) preparation with the other collaborators of the final protocols, data systems, and study forms; specifically, identifying the optimal means to assure the highest possible quality of colposcopic examinations and cervical biopsies; (2) prior to enrollment, optimizing and standardizing clinic colposcopic and biopsy procedures, equipment, and supplies; (3) during the conduct of the Trial, monitoring and optimizing all aspects of the Protocol related to colposcopy and biopsies including the design and conduct of experiments to assess the accuracy of colposcopic examinations, particularly the assessment of lesion severity and placement of biopsies; (4) ongoing participation in the overall supervision of the Trial via the Steering Committee and its subcommittees; and (5) cooperation with all Trial administrative functions, including reporting, data management, and proper handling of Trial-related biospecimens. Requests for this solicitation must be in writing and reference the RFP Number. INQUIRIES Requests for this solicitation must be in writing and reference the RFP Number, NCI-CN-55042-07. The RFP is tentatively scheduled for release on December 1, 1994 and proposals will be due approximately January 30, 1995. No collect calls will be accepted. Requests should be mailed to: Victor S. Buyny Research Contracts Branch, PCCS National Cancer Institute Executive Plaza South, Room 635 6120 Executive Boulevard, MSC 7226 Bethesda, MD 20892-7226 Telephone: (301) 496-8603 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |